BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 330 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $58,531,000 | +21.0% | 387,191 | +16.6% | 0.02% | +25.0% |
| Q2 2022 | $48,375,000 | -19.6% | 331,995 | -34.5% | 0.01% | +20.0% |
| Q1 2022 | $60,132,000 | -49.3% | 507,144 | -41.1% | 0.01% | +233.3% |
| Q4 2021 | $118,614,000 | +77.2% | 860,700 | +78.6% | 0.00% | -70.0% |
| Q3 2021 | $66,933,000 | -30.1% | 481,847 | -51.2% | 0.01% | -23.1% |
| Q2 2021 | $95,814,000 | +127.8% | 986,969 | +60.4% | 0.01% | +85.7% |
| Q1 2021 | $42,066,000 | -81.4% | 615,456 | -76.7% | 0.01% | -61.1% |
| Q4 2020 | $226,424,000 | +349.3% | 2,641,730 | +240.8% | 0.02% | +80.0% |
| Q3 2020 | $50,394,000 | -18.4% | 775,165 | -8.2% | 0.01% | -33.3% |
| Q2 2020 | $61,749,000 | +60.0% | 844,592 | -25.5% | 0.02% | +15.4% |
| Q1 2020 | $38,592,000 | -21.7% | 1,134,042 | +25.2% | 0.01% | -13.3% |
| Q4 2019 | $49,298,000 | +18.6% | 905,533 | -9.1% | 0.02% | +7.1% |
| Q3 2019 | $41,580,000 | -62.3% | 996,645 | -60.5% | 0.01% | +7.7% |
| Q2 2019 | $110,362,000 | +273.2% | 2,520,307 | +338.6% | 0.01% | 0.0% |
| Q1 2019 | $29,574,000 | +295.5% | 574,607 | +184.2% | 0.01% | +225.0% |
| Q4 2018 | $7,478,000 | -14.9% | 202,199 | -13.6% | 0.00% | +33.3% |
| Q3 2018 | $8,790,000 | -3.2% | 234,100 | +1.9% | 0.00% | +50.0% |
| Q2 2018 | $9,082,000 | -6.6% | 229,810 | -39.2% | 0.00% | -33.3% |
| Q1 2018 | $9,728,000 | +276.3% | 377,672 | +294.2% | 0.00% | – |
| Q4 2017 | $2,585,000 | +756.0% | 95,814 | +1086.8% | 0.00% | – |
| Q3 2017 | $302,000 | – | 8,073 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 490,422 | $12,755,876 | 13.24% |
| FNY Investment Advisers, LLC | 30 | $0 | 0.00% |